Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a publicly traded Healthcare sector company. As of May 21, 2026, KMTS trades at $20.76 with a market cap of $1.14B and a P/E ratio of -4.05. KMTS moved +4.70% today. Year to date, KMTS is -14.99%; over the trailing twelve months it is -16.69%. Its 52-week range spans $13.25 to $30.00. Analyst consensus is strong buy with an average price target of $27.00. Rallies surfaces KMTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for KMTS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $20.76 |
| Market Cap | $1.14B |
| P/E Ratio | -4.05 |
| EPS | $-5.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.00 |
| 52-Week Low | $13.25 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $59.81M |
| Net Income | $-113.81M |
| Gross Margin | 40.48% |
6 analysts cover KMTS: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.00.